Compare VTSI & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTSI | QTTB |
|---|---|---|
| Founded | 1993 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.1M | 44.3M |
| IPO Year | 1999 | 2018 |
| Metric | VTSI | QTTB |
|---|---|---|
| Price | $3.76 | $6.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $13.00 |
| AVG Volume (30 Days) | 50.1K | ★ 349.4K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 136.78 |
| EPS | 0.02 | ★ 2.42 |
| Revenue | $185,971.00 | ★ $53,737,000.00 |
| Revenue This Year | $28.39 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $189.00 | ★ $2.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.55 | $1.38 |
| 52 Week High | $7.47 | $8.05 |
| Indicator | VTSI | QTTB |
|---|---|---|
| Relative Strength Index (RSI) | 37.06 | 54.11 |
| Support Level | N/A | $3.49 |
| Resistance Level | $4.68 | $7.80 |
| Average True Range (ATR) | 0.25 | 0.93 |
| MACD | -0.07 | -0.13 |
| Stochastic Oscillator | 18.62 | 34.32 |
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.